Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches

Gonzalo Sapisochin,Jordi Bruix

DOI: https://doi.org/10.1038/nrgastro.2016.193

2017-01-05

Abstract:Key PointsLiver transplantation is the best treatment option for patients with hepatocellular carcinoma (HCC), but selection of the best candidates is critical to achieving good results and not misusing a valuable resourceAllocation of liver grafts for patients with HCC is complicated and mainly depends on the number of patients on the waiting list and organ availability in each regionSurgical techniques to expand the available organ donor pool include living donor liver transplantation, donation after circulatory death and split liversThe outcomes for patients with HCC using these surgical techniques are good and therefore might be safely used in this contextExpanding the indications for liver transplantation for HCC increases the risk of tumour recurrence; this recurrence might be treated in selected cases to improve patient survivalDirect-acting antiviral agents for HCV will probably affect the management of patients with HCC listed for liver transplantation, but its role in this context is still undergoing active research

gastroenterology & hepatology